Professional Documents
Culture Documents
www.elsevier.com/locate/powtec
Abstract
The objective was to develop a suitable laser diffraction particle sizing method for cohesive lactose present either as agglomerates or adhered
onto coarse lactose carriers. Micronised lactose (ML) was prepared by fluid energy milling. Particle size distributions (PSD) were determined by
laser diffraction (Malvern Master Sizer S, U.K.). Ethanol, propan-2-ol, 1-butanol and isooctane were selected as dispersants. Sonication for 5 min
caused de-agglomeration of agglomerates initially formed in ethanol, propan-2-ol, and 1-butanol; the volume mean diameter (VMD) of ML in
ethanol, propan-2-ol, and 1-butanol was 2.9 μm, 2.8 μm and 2.5 μm, respectively. Coarse lactose (Foremost 95 (F95)) showed a mono-modal
distribution in all dispersants with a VMD of 117 μm in propan-2-ol. The robustness of particle sizing of ML in each dispersant was determined
over time. Propan-2-ol was the most suitable dispersant for ML, as the PSD (VMD of 2.8 ± 0.3 μm) did not change over a 3 h period. In
comparison, for ethanol, VMD of FL was stable only for 30 min, but then increased from 2.9 μm to 9.0 μm after 3 h. The particle size changes
over time occurring in ethanol were related to dissolution of fine lactose and possible re-crystallisation with subsequent increased VMD. ML
added to coarse lactose and existing as agglomerated particles or as particles adhered to the coarse lactose could be determined with the use of a
carefully selected sonication time to minimise coarse lactose comminution.
© 2007 Elsevier B.V. All rights reserved.
Keywords: Laser diffraction particle sizing; Cohesive lactose; Dispersants; Agglomeration; Particle adhesion
Fig. 1. Scanning electron micrographs of lactose particle. (A) micronised lactose (Magnification of ×3.0K), (B) non-micronised lactose (Magnification of ×1.0K) and
(C) non-micronised lactose (Magnification of ×200K).
lactose was the key factor in controlling drug dispersion from 2.3. Particle size analysis method
drug-lactose mixtures of inhalation [4,5].
The selection of a reliable particle size analysis methodology The particle size of lactose was measured by laser diffraction
to measure the particle size distribution of micronised lactose (Malvern Mastersizer S, Malvern Instruments Ltd., U.K.) using
and coarse lactose containing adhered cohesive lactose is the 300 RF lens and the small volume sample presentation unit
essential to characterize the influence of fine lactose on the drug (capacity 150 ml). Approximately 500 mg of lactose powder
dispersion in respiratory drug delivery. Various strategies to was dispersed in 5 ml of propan-2-ol with the aid of a sonication
disperse lactose for laser diffraction particle size analysis have
been employed including: dispersion of lactose powder in
chloroform containing a few drops of span 85 and sonication for
1 min [3]; dispersion in ethanol with sonication for 3 min [5];
dispersion of lactose in butan-1-ol with the aid of sonication for
3 min [4]. However, method validation, such as the effect of
dispersants and sonication time on the size measurement of fine
lactose, has not been disclosed. The objective of this study,
therefore, was to investigate the influence of the interactive
behaviour of micronised lactose on its particle size analysis and
to develop a suitable methodology for particle size measure-
ment of cohesive lactose samples using laser diffraction.
2. Experimental
2.1. Materials
Fig. 4. The influence of storage time in different dispersants on the volume mean
diameter of micronised lactose determined using laser diffraction.
in a water bath for 3 min. The sonicated sample was added drop-
wise into sample cell containing 150 ml of propan-2-ol until an
obscuration between 10–30% was obtained. Size measurement
of each sample was performed using 2000 sweeps and analysed
with the reference refractive index of lactose (1.533) and
propan-2-ol (1.378) and estimated imaginary refractive index of
lactose of 0.1. The average particle size distribution was
measured from 5 replicates of each sample. The percentage of
particles below 5 μm and 10 μm were determined using
cumulative frequency distribution (undersized) curve. The
residual value was always below 1%. Others dispersants
were: Absolute ethanol (refractive index of 1.361), 1-butanol
(1.399) and isooctane (1.389). Sonication times (0, 0.5, 1, 3, 5,
8, and 15 min) and the robustness of the particle size analysis
were determined over a period of 0 to 3 h. The average particle
size was described by the volume mean diameter (VMD).
3.2. Effect of sonication time 3.3. PSD changes of micronised lactose in different dispersant
The effect of the sonication time was investigated using The VMD changes of micronized lactose dispersed after
different dispersants (ethanol, propan-2-ol, 1-butanol and iso- sonication for 5 min were compared during storage over
octane) for the period of 0 to 15 min. PSD of ML was 180 min in ethanol, propan-2-ol and 1-butanol (Fig. 4).
significantly changed from bimodal distribution to the mono- Propan-2-ol was the most suitable dispersants for the ML,
modal distribution after 3 min, demonstrated by its behaviour in where the VMD of 2.8 ± 0.3 μm did not change over 3 h. The
propan-2-ol (Fig. 3A). Sonication gave a significant reduction PSD confirmed that the distribution was also consistent over the
in agglomeration for all dispersants. The VMD of ML was 3 h period (Fig. 5A). Both d10% and d90% were stable after 3 h
reduced in propan-2-ol, ethanol and 1-butanol from 53.9 to in the propan-2-ol, the value ranging from 1.2 to 1.3 μm for and
2.4 μm; 17.6 to 2.7 μm and 57.2 to 2.5 μm respectively after 4.8 to 5.4 μm respectively. There was no evidence of
agglomeration. VMD of the ML was not significantly changed
Table 1 even after 20 h of storage in propan-2-ol (VMD of 3.1 μm).
Summary of particle size parameters of Inhalac 120 and micronised lactose The VMD of the ML in1-butanol was stable for the 60 min
(Standard deviations are within brackets)
(VMD of 2.9 ± 0.03 μm); however, the VMD had increased
Sample d10% (μm) VMD (μm) D90% (μm) b10 μm (%) from 2.9 to 4.8 μm after 180 min (P b 0.05) (Fig. 4). The d10% of
Inhalac 120 115.8 (0.3) 162.1 (0.3) 215.3 (0.7) 1.4 (0.2) the ML was consistent during storage (1.2 ± 0.04 μm); however,
5.5 μm ML 1.2 (0.1) 5.5 (0.1) 10.4 (0.1) 89.6 (0.3) the d90% increased slightly from 4.8 to 5.6 μm and some
Inhalac and 5% of ML 103.1 (2.9) 152.7 (1.2) 209.3 (3.6) 5.8 (0.6)
agglomeration was evident after 180 min at about 50 μm.
94 H. Adi et al. / Powder Technology 179 (2007) 90–94
The re-agglomeration of particles is initiated through achieve dispersion. Sonication was essential for fine lactose de-
particulate collisions because of their Brownian motion. If the agglomeration and detachment from carrier particles. Sonica-
attractive forces prevail during the interaction, agglomerates can tion over 3 min was necessary to recover all ML from the coarse
develop. The attractive forces are mostly due to London-Van der lactose; however longer sonication time may result in the coarse
Waals forces; repulsive forces originate from several sources [9] particle break up. The particle size changes over time occurring
including electrostatic repulsion, steric hindrance or repulsive in ethanol and 1-butanol were probably related to dissolution
hydration forces in the interfacial region. The key requirement and possible re-crystallisation with subsequent increased VMD.
for stabilisation is that the net repulsive term exceeds the net
attractive term. Acknowledgments
In absolute ethanol, the VMD of ML was stable for 30 min.
The VMD significantly increased from 2.9 to 9.0 μm after Handoko Adi was supported by Departmental Scholarship,
180 min (P b 0.05). The rapid increase in the VMD was due to Department of Pharmaceutics, Monash University. All lactose
particle dissolution and agglomeration. In Fig. 5B, the change in samples were donated by Foremost Farms, USA; Meggle
PSD was clearly seen, with d90% increasing from 4.7 to 9.0 μm GmbH, Germany; and Lactose New Zealand, NZ. We would
while the d10% was constant (1.2 ± 0.1 μm). Particle agglom- like to extend our thanks to Micro-powders Ltd. for the
eration occurred with the development of a second distribution micronised lactose.
around 50 μm after 60 min.
References
3.4. Recovery of added fine lactose to a coarse lactose carrier
[1] J. Visser, An Invited review, Van der Waals and other cohesive forces
Inhalac 120 was used as model carrier due to its relatively affecting powder fluidization, Powder Technology 58 (1989) 1–10.
[2] M.M. De Villiers, Influence of cohesive properties of micronized drug
low percentage of inherent fine lactose (FL) b10 μm (Table 1). powders on particle size analysis, Journal of Pharamaceutical and Biomedical
FL (5.5 μm; 5%) was mixed with Inhalac 120 and was expected Analysis 13 (3) (1995) 191–198.
to form cohesive fine lactose agglomerates or adhere on the [3] S.K. Tee, C. Marriott, X.M. Zeng, G.P. Martin, The use of different sugars as
carrier surface. In order to completely detach and de- fine and coarse carriers for aerosolised salbutamol sulphate, International
agglomerate the fine lactose in the presence of the Inhalac Journal of Pharmaceutics 208 (2000) 111–123.
[4] N. Islam, P. Stewart, I. Larson, P. Hartley, Lactose surface modification
120 (i.e. recover 5.8% of FL b 10 μm), an appropriate sonication decantation: are drug-fine lactose ratios the key to better dispersion of
time should be used to disperse the FL, but not to comminute salmeterol xinafoate from lactose-interactive mixture? Pharmaceutical Re-
the lactose carrier. search 21 (2004) 492–499.
The effect of sonication to the inhalac 120 was investigated. [5] M.D. Louey, P.J. Stewart, Particle interaction involved in aerosol dispersion
of ternary interactive mixtures, Pharmaceutical Research 19 (2002)
No significant change in percentage of FL b 10 μm (2.2%)
1524–1531.
occurred during the sonication times from 1-5 min; however [6] G. Nichols, S. Byard, M.J. Bloxham, J. Botterill, N.J. Dawson, A. Dennis,
further sonication to 20 min increased the percentage of FL V. Diart, N.C. North, J.D. Sherwood, A Review of the terms agglomerate
b 10 μm indicating possible Inhalac 120 break up. and aggregate with a recommendation for nomenclature used in powder and
During sonication of lactose mixture containing 5% added particle characterization, Journal of Pharmaceutical Science 91 (10) (2002)
ML, the percentage of FL b 10 μm significantly increased from 2103–2110.
[7] J.H. David, H.R. Brian, M.R. Margaret, Ultrasonic characterisation of
1.8% at 1 min to 6.2% (P b 0.05) after 3 min. Sonication of colloidal dispersion: detection of flocculation and adsorbed layers, Colloids
lactose mixture for 3 min was considered to be optimum since and Surfaces. B, Biointerfaces 12 (1999) 359–371.
added fine lactose was recovered and previous studies on [8] M. Karel, Ultrasonic investigations in a coal mine, Ultrasonics 34 (1996)
Inhalac 120 alone showed no comminution in this time-frame. 421–423.
The percentage of FL b10 μm showed no significant different [9] R.E. Gordon, W.T. Rosanske, D.E. Fonner, in: A.L. Herbert, M.R. Martin,
S.B. Gilbert (Eds.), Granulation Technology and Tablet Characterization,
(P N 0.05) between the recovered FL from the Inhalac 120 and Pharmaceutical Dosage Forms: Disperse Systems, vol. 1, Marcel Dekker,
ML mixture and expected theoretical concentration of FL Inc., New York, 1988, pp. 245–348.
b 10 μm in the mixture (6.2% compared to 5.8%, respectively).
Further sonication resulted in the comminution of the coarse
lactose (Inhalac 120) particles (Table 2).
4. Conclusion